This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Aug;25(8):1127-33.

doi: 10.1016/0277-5379(89)90404-5.

Tumour spheroid technology in cancer therapy research

J Carlsson¹, T Nederman

Affiliations

PMID: 2670583
DOI: 10.1016/0277-5379(89)90404-5

Review

Tumour spheroid technology in cancer therapy research

J Carlsson et al. Eur J Cancer Clin Oncol. 1989 Aug.

. 1989 Aug;25(8):1127-33.

doi: 10.1016/0277-5379(89)90404-5.

Authors

J Carlsson¹, T Nederman

Affiliation

¹ Department of Radiation Sciences, Uppsala University, Sweden.

PMID: 2670583
DOI: 10.1016/0277-5379(89)90404-5

No abstract available

PubMed Disclaimer

Comment on

Etoposide (VP-16) uptake by tumour spheroids and activity in the presence of Brij 30, formulation additives and sodium salicylate.
Cook JM, Florence AT, Russell J, Wheldon TE. Cook JM, et al. Eur J Cancer Clin Oncol. 1989 Feb;25(2):311-8. doi: 10.1016/0277-5379(89)90024-2. Eur J Cancer Clin Oncol. 1989. PMID: 2702985

Similar articles

Inhibition of tumour cell growth by a novel dihydropyridine derivative.
Gietzen K, Abdallah F, Bai G. Gietzen K, et al. Eur J Cancer. 1990;26(8):922-3. doi: 10.1016/0277-5379(90)90206-9. Eur J Cancer. 1990. PMID: 2145943 No abstract available.
Tumour cell morphometry and response to chemotherapy in ovarian cancer.
Weger AR, Ludescher C, Mikuz G, Hausmaninger H, Lindholm J. Weger AR, et al. Lancet. 1988 Oct 29;2(8618):1020-1. doi: 10.1016/s0140-6736(88)90772-6. Lancet. 1988. PMID: 2902454 No abstract available.
The evolution of curative cancer therapy.
Frei E 3rd. Frei E 3rd. Mt Sinai J Med. 1992 Oct;59(5):408-11. Mt Sinai J Med. 1992. PMID: 1435837 Review. No abstract available.
Combined modality therapy using cytotoxic agents and radiation therapy.
Howes AE, Coleman CN, Phillips TL, Sutherland R. Howes AE, et al. Am J Clin Oncol. 1988 Jun;11(3):304-12. doi: 10.1097/00000421-198806000-00007. Am J Clin Oncol. 1988. PMID: 3289363 Review. No abstract available.
Identification of agents that induce apoptosis of multicellular tumour spheroids: enrichment for mitotic inhibitors with hydrophobic properties.
Fayad W, Rickardson L, Haglund C, Olofsson MH, D'Arcy P, Larsson R, Linder S, Fryknäs M. Fayad W, et al. Chem Biol Drug Des. 2011 Oct;78(4):547-57. doi: 10.1111/j.1747-0285.2011.01170.x. Epub 2011 Jul 29. Chem Biol Drug Des. 2011. PMID: 21726416

See all similar articles

Cited by

Three-dimensional and co-culture models for preclinical evaluation of metal-based anticancer drugs.
Schreiber-Brynzak E, Klapproth E, Unger C, Lichtscheidl-Schultz I, Göschl S, Schweighofer S, Trondl R, Dolznig H, Jakupec MA, Keppler BK. Schreiber-Brynzak E, et al. Invest New Drugs. 2015 Aug;33(4):835-47. doi: 10.1007/s10637-015-0260-4. Epub 2015 Jun 21. Invest New Drugs. 2015. PMID: 26091914
Incorporation of iododeoxyuridine in multicellular glioma spheroids: implications for DNA-targeted radiotherapy using Auger electron emitters.
Neshasteh-Riz A, Angerson WJ, Reeves JR, Smith G, Rampling R, Mairs RJ. Neshasteh-Riz A, et al. Br J Cancer. 1997;75(4):493-9. doi: 10.1038/bjc.1997.86. Br J Cancer. 1997. PMID: 9052399 Free PMC article.
A multicellular tumor spheroid model of cellular immunity against head and neck cancer.
Sacks PG, Taylor DL, Racz T, Vasey T, Oke V, Schantz SP. Sacks PG, et al. Cancer Immunol Immunother. 1990;32(3):195-200. doi: 10.1007/BF01771457. Cancer Immunol Immunother. 1990. PMID: 2289213 Free PMC article.
Precision Medicine Gains Momentum: Novel 3D Models and Stem Cell-Based Approaches in Head and Neck Cancer.
Affolter A, Lammert A, Kern J, Scherl C, Rotter N. Affolter A, et al. Front Cell Dev Biol. 2021 Jul 8;9:666515. doi: 10.3389/fcell.2021.666515. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34307351 Free PMC article. Review.
Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.
Mehta G, Hsiao AY, Ingram M, Luker GD, Takayama S. Mehta G, et al. J Control Release. 2012 Dec 10;164(2):192-204. doi: 10.1016/j.jconrel.2012.04.045. Epub 2012 May 18. J Control Release. 2012. PMID: 22613880 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions